As reported by IPWatchdog, Moderna is facing lawsuits in the United States from biotech firms, Arbutus Biopharma Corporation and Genevant Sciences GmbH.
Both companies allege that Moderna has infringed six of their U.S. patents relating to lipid nanoparticle (“LNP”) delivery technology. LNP delivery systems are crucial for mRNA therapies like Moderna’s COVID-19 vaccine by allowing treatments to bypass the human immune system without being destroyed.
Moderna has reportedly denied all allegations and vowed to vigorously defend itself against the claims made against it in court.
The plaintiffs in this action are seeking compensation, rather than an injunction, which is typically sought in such actions. If infringement is found, compensation through damages would likely be assessed through a “reasonable royalty”.
Carnegie Hall has reportedly commenced an action against Carnegie Diner and Café for trademark infringement.In its complaint filed with the United States District Court, Southern District of New York…
In Bell Canada et al. v. Millennium Funding, Inc. et al., 2025 FCA 153, Bell Canada and Bell Aliant (collectively, “Bell”) appealed an order granting the Respondents’ (collectively, “Millenium…
Goyard, the Parisian brand established in 1853 and still privately owned, has reportedly faced a surge in counterfeit bags flooding the market. The company refrains from advertising, avoids e-commerce…
The US Supreme Court has declined to revisit a copyright dispute over alleged similarities between Ed Sheeran’s 2014 hit, “Thinking Out Loud”, and Marvin Gaye’s 1973 classic, “Let’s Get It On…
In McCain Foods Limited v. J.R. Simplot Company 2024 FC 1729, the Federal Court considered the circumstances in which an examination for discovery of a person, other than a person examined under Rule…
Salt-N-Pepa are reportedly suing their record label, Universal Music Group (“UMG”), to attempt to reclaim rights to their music, including hip-hop staples “Shoop” and “Push It”. As reported by the New…
